| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
6,262 |
5,803 |
$266K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
734 |
719 |
$33K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
440 |
424 |
$31K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
847 |
831 |
$13K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
509 |
448 |
$13K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
245 |
166 |
$11K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
441 |
431 |
$7K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
110 |
93 |
$7K |
| 87634 |
|
135 |
132 |
$7K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
130 |
129 |
$4K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
46 |
46 |
$2K |
| 81003 |
|
355 |
340 |
$776.91 |
| 87807 |
|
54 |
49 |
$521.12 |
| 81025 |
|
12 |
12 |
$62.04 |